Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an

EGFR mutations liquid biopsy molecular diagnostics next-generation sequencing non-small cell lung cancer precision medicine resistance mechanisms

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
19 May 2022
Historique:
received: 29 03 2022
revised: 15 05 2022
accepted: 17 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

EGFR tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients with activating

Identifiants

pubmed: 35626421
pii: diagnostics12051266
doi: 10.3390/diagnostics12051266
pmc: PMC9141594
pii:
doi:

Types de publication

Case Reports

Langues

eng

Subventions

Organisme : Roche Farma
ID : IIS La Fe 2015/0713
Organisme : Consellería de Educación, Investigación, Cultura y Deporte de la Comunidad Valenciana
ID : ACIF/2018/258

Références

Lung Cancer. 2019 Nov;137:149-156
pubmed: 31600593
Int J Mol Sci. 2019 Jan 03;20(1):
pubmed: 30609789
Front Oncol. 2022 Apr 04;12:860563
pubmed: 35444951
Cancer Discov. 2017 Jul 20;:
pubmed: 28729406
Cancer Treat Rev. 2020 Jun;86:102019
pubmed: 32251926
Clin Lung Cancer. 2009 Jul;10(4):281-9
pubmed: 19632948
Future Oncol. 2019 Feb;15(6):637-652
pubmed: 30404555
J Thorac Dis. 2020 Nov;12(11):7048-7056
pubmed: 33282410
Int J Med Sci. 2019 Jun 10;16(7):981-989
pubmed: 31341411
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Annu Rev Med. 2020 Jan 27;71:117-136
pubmed: 31986082
Nat Rev Clin Oncol. 2014 Aug;11(8):473-81
pubmed: 24981256
Cancer Biol Med. 2016 Mar;13(1):12-8
pubmed: 27144059
Br J Cancer. 2019 Oct;121(9):725-737
pubmed: 31564718
Clin Cancer Res. 2021 Oct 1;27(19):5258-5271
pubmed: 34301751
Ann Lab Med. 2021 Jan;41(1):25-43
pubmed: 32829577
Nat Rev Cancer. 2016 Aug;16(8):525-37
pubmed: 27388699
J Thorac Oncol. 2019 Oct;14(10):1784-1793
pubmed: 31228622
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
Lung Cancer. 2020 Sep;147:123-129
pubmed: 32693293
Future Oncol. 2022 May;18(14):1757-1775
pubmed: 35232247
Front Oncol. 2019 Mar 05;9:129
pubmed: 30891428
Ann Oncol. 2020 Nov;31(11):1491-1505
pubmed: 32853681
J Clin Oncol. 2018 Jun 1;36(16):1631-1641
pubmed: 29504847
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
PLoS One. 2019 Dec 20;14(12):e0226853
pubmed: 31860648
J Clin Oncol. 2017 Sep 10;35(26):3065-3074
pubmed: 28498782
Nature. 2015 Aug 6;524(7563):47-53
pubmed: 26168399

Auteurs

Javier Simarro (J)

Molecular Biology Unit, Service of Clinical Analysis, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Clinical and Translational Cancer Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.

Gema Pérez-Simó (G)

Molecular Biology Unit, Service of Clinical Analysis, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Clinical and Translational Cancer Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.

Nuria Mancheño (N)

Pathology Department, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Carlos Francisco Muñoz-Núñez (CF)

Radiology Department, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Enrique Cases (E)

Pulmonology Department, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Óscar Juan (Ó)

Medical Oncology Department, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Sarai Palanca (S)

Molecular Biology Unit, Service of Clinical Analysis, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Clinical and Translational Cancer Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.
Biochemistry and Molecular Biology Department, Universidad de Valencia, Burjassot, 46100 Valencia, Spain.

Classifications MeSH